Medication info

Dongkwang Candesartan Tablets 8mg (Candesartan Cilexetil)

Prescription medicationTabletOralExpired
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
A round, pale pink tablet with a convex shape on both sides.
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201903326 · Approved 2019.05.22 · Insurance code 645906530

This product's status changed to Expired on 2024.05.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This drug should be taken at a consistent time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient’s response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient’s response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, depending on the patient’s tolerability. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. It is also effective in managing symptoms in heart failure patients with impaired left ventricular systolic function, particularly when additional treatment with ACE inhibitors is needed or when there is intolerance to ACE inhibitors. This helps improve cardiac function and assists patients in daily living.

How to take

Adult dose

This drug should be taken at a consistent time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient’s response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient’s response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, depending on the patient’s tolerability. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy of this drug have not been established in adolescents and children aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant and women who are breastfeeding should not take this medication. Patients with severely impaired liver function or certain genetic lactose intolerance should also not use this medication. Elderly patients, those with hyperkalemia, patients with mild liver impairment, and patients with heart valve disease should use this medication cautiously and monitor blood pressure and kidney function frequently during treatment. Side effects of this medication can include dizziness, back pain, respiratory infections, and in heart failure patients, the risks of hypotension, hyperkalemia, and deterioration of kidney function. Regular blood tests for serum potassium and creatinine levels are necessary. Serious side effects, such as decreased blood cell counts, liver function abnormalities, skin rashes, and angioedema, can occur, so any unusual symptoms should be reported to a doctor immediately. When taking this medication with other antihypertensives, effects may be increased, so it must be taken according to a doctor's instructions. In particular, caution is necessary when taken with potassium-sparing diuretics or potassium supplements, as this could dangerously raise potassium levels in the blood. If you are scheduled for surgery or anesthesia, it is advisable to stop taking this medication 24 hours prior to the procedure. Overdose can lead to hypotension, dizziness, rapid heartbeat, etc., and immediate medical attention should be sought for appropriate treatment. The safety and effectiveness of this medication in children and adolescents have not been sufficiently established, so it is recommended not to administer it to those under 18 years of age. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • weakness
  • fever
  • sensory abnormalities
  • indigestion
  • gastroenteritis
  • tachycardia
  • palpitations
Show 66 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • fainting
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbance
  • decreased libido
  • amnesia
  • appetite loss
  • increased appetite
  • tinnitus
  • taste disorder
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain storage temperatures between 1°C and 30°C. Proper storage helps ensure the safety of the medication's efficacy.

Appearance and packaging

Appearance

A round, pale pink tablet with a convex shape on both sides.

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.